These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 21669125)
1. Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage. Li N; Worthmann H; Deb M; Chen S; Weissenborn K Neurol Res; 2011 Jun; 33(5):541-8. PubMed ID: 21669125 [TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier disruption induced by hemoglobin in vivo: Involvement of up-regulation of nitric oxide synthase and peroxynitrite formation. Ding R; Chen Y; Yang S; Deng X; Fu Z; Feng L; Cai Y; Du M; Zhou Y; Tang Y Brain Res; 2014 Jul; 1571():25-38. PubMed ID: 24814387 [TBL] [Abstract][Full Text] [Related]
3. Acute and conditioned hypoxic tolerance augmented by endothelial nitric oxide synthase inhibition in mice. Song MY; Zwemer CF; Whitesall SE; D'Alecy LG J Appl Physiol (1985); 2007 Feb; 102(2):610-5. PubMed ID: 17068215 [TBL] [Abstract][Full Text] [Related]
4. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Pluta RM Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036 [TBL] [Abstract][Full Text] [Related]
5. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance. Toutouzas K; Riga M; Stefanadi E; Stefanadis C Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879 [TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. De Gennaro Colonna V; Bianchi M; Pascale V; Ferrario P; Morelli F; Pascale W; Tomasoni L; Turiel M Med Sci Monit; 2009 Apr; 15(4):RA91-101. PubMed ID: 19333216 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Feng M; Liu L; Guo Z; Xiong Y Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305 [TBL] [Abstract][Full Text] [Related]
11. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Jiang DJ; Jia SJ; Yan J; Zhou Z; Yuan Q; Li YJ Biochem Biophys Res Commun; 2006 Oct; 349(2):683-93. PubMed ID: 16959216 [TBL] [Abstract][Full Text] [Related]
12. Endogenous inhibitors of nitric oxide and preeclampsia: a review. Slaghekke F; Dekker G; Jeffries B J Matern Fetal Neonatal Med; 2006 Aug; 19(8):447-52. PubMed ID: 16966108 [TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition. Zsuga J; Gesztelyi R; Török J; Kéki S; Bereczki D Med Hypotheses; 2005; 65(6):1091-8. PubMed ID: 16125868 [TBL] [Abstract][Full Text] [Related]
14. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis. Laleman W; Omasta A; Van de Casteele M; Zeegers M; Vander Elst I; Van Landeghem L; Severi T; van Pelt J; Roskams T; Fevery J; Nevens F Hepatology; 2005 Dec; 42(6):1382-90. PubMed ID: 16317694 [TBL] [Abstract][Full Text] [Related]